Detalhe da pesquisa
1.
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia.
N Engl J Med
; 388(19): 1739-1754, 2023 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37163621
2.
Acalabrutinib, venetoclax and obinutuzumab in relapsed CLL: Final efficacy and ctDNA analysis of the CLL2-BAAG trial.
Blood
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38620072
3.
Virus-reactive T cells expanded in aplastic anemia eliminate hematopoietic progenitor cells by molecular mimicry.
Blood
; 143(14): 1365-1378, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277625
4.
The IL-7R antagonist Lusvertikimab reduces leukemic burden in xenograft-ALL via antibody-dependent cellular phagocytosis.
Blood
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38518105
5.
Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma.
Blood
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588489
6.
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
Blood
; 143(17): 1738-1751, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215390
7.
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
Blood
; 143(14): 1391-1398, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153913
8.
NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol.
Blood
; 141(5): 529-533, 2023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240445
9.
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.
Blood
; 142(5): 446-459, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37172204
10.
Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALL.
Blood
; 140(1): 45-57, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452517
11.
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemia.
Am J Hematol
; 99(4): 586-595, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317420
12.
Flow cytometric minimal residual disease assessment in B-cell precursor acute lymphoblastic leukaemia patients treated with CD19-targeted therapies - a EuroFlow study.
Br J Haematol
; 197(1): 76-81, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34881427
13.
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
Blood
; 136(25): 2851-2863, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113552
14.
The impact of phenotypic heterogeneity of tumour cells on treatment and relapse dynamics.
PLoS Comput Biol
; 17(2): e1008702, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33577569
15.
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study.
Mod Pathol
; 34(1): 59-69, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32999413
16.
DUX4r, ZNF384r and PAX5-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch.
Haematologica
; 106(8): 2066-2075, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32646889
17.
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
N Engl J Med
; 376(9): 836-847, 2017 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28249141
18.
Automation of Amplicon-Based Library Preparation for Next-Generation Sequencing by Centrifugal Microfluidics.
Anal Chem
; 92(19): 12833-12841, 2020 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32842730
19.
Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia.
Blood
; 141(13): 1640-1644, 2023 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36450137
20.
Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation.
Blood
; 131(13): 1464-1475, 2018 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29348129